Predictive Oncology (Precision Therapeutics)
Home - Predictive Oncology
United States · $21.3M raised
- Business Model
- B2B
- Website
- predictive-oncology.com
- Total Funding
- $21.3M
- Last Round
- $21.3M Venture RoundJun 2021
- Rounds
- 1
About
AI-driven oncology drug development platform using tumor data to improve cancer treatment outcomes; rebranding to Axe Compute for GPU infrastructure.
Summary
Predictive Oncology (Precision Therapeutics) is an Artificial Intelligence company based in United States. It has raised $21.3M in total across 1 round, most recently a $21.3M Venture Round round in Jun 2021. Investors include Bain Capital Ventures.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company